MedTrace Logo

Semi-automatic Segmentation Method for Determining 177Lu-DOTATATE Tumor Dosimetry

NCT06460467 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2025-03-04

No results posted yet for this study

Summary

The aim of this study was to compare a semi-automatic segmentation method with manual reference segmentation to determine an overall tumor volume on post-therapy scintigraphy at D1 in patients treated with 177Lu-DOTATATE for meningioma or neuroendocrine tumor for dosimetric calculation.

Conditions

  • Meningioma

Interventions

DEVICE

scintigraphy of 177Lu-DOTATATE

The medical device under study is a hybrid wide-field CZT solid-state camera, the VERITON-CT ™ camera.

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-01-01
Completion
2025-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06460467 on ClinicalTrials.gov